{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:14:11Z","timestamp":1788318851776,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jchf.2026.103018","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T01:14:13Z","timestamp":1774660453000},"page":"103018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening Strategies for Identification of Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","volume":"14","author":[{"given":"Anthony E.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-2541","authenticated-orcid":false,"given":"Faraz S.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6754-3670","authenticated-orcid":false,"given":"Trejeeve","family":"Martyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-3737","authenticated-orcid":false,"given":"Parag","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.jchf.2026.103018_bib1","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jchf.2026.103018_bib2","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jchf.2026.103018_bib3","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/HCO.0000000000001198","article-title":"New therapies to treat cardiac amyloidosis","volume":"40","author":"Nguyen","year":"2025","journal-title":"Curr Opin Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2026.103018_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Griffin","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103018_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jchf.2026.103018_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jchf.2026.103018_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of cardiac amyloidosis\u2013associated heart failure hospitalizations among fee-for-service Medicare beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.jchf.2026.103018_bib10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2026.103018_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40119-021-00219-5","article-title":"Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review","volume":"10","author":"Rozenbaum","year":"2021","journal-title":"Cardiol Ther"},{"issue":"4","key":"10.1016\/j.jchf.2026.103018_bib12","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/ehf2.15311","article-title":"Delays in diagnosis and treatment of ATTR cardiac amyloidosis: a real-world data analysis","volume":"12","author":"Vogel","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.jchf.2026.103018_bib13","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1002\/ehf2.14517","article-title":"Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records","volume":"10","author":"Moya","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"18","key":"10.1016\/j.jchf.2026.103018_bib14","article-title":"Delayed diagnoses of cardiac amyloidosis","volume":"30","author":"Kersey","year":"2025","journal-title":"JACC Case Rep"},{"issue":"4","key":"10.1016\/j.jchf.2026.103018_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.jchf.2026.103018_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13449","article-title":"A simple echocardiographic score to rule out cardiac amyloidosis","volume":"51","author":"Aimo","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jchf.2026.103018_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ahj.2020.11.006","article-title":"A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy","volume":"232","author":"Zhang","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2026.103018_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13506129.2017.1333956","article-title":"Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis","volume":"24","author":"Cariou","year":"2017","journal-title":"Amyloid"},{"issue":"11","key":"10.1016\/j.jchf.2026.103018_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCIMAGING.122.014645","article-title":"Optimal echocardiographic parameters to improve the diagnostic yield of Tc-99m-bone avid tracer cardiac scintigraphy for transthyretin cardiac amyloidosis","volume":"15","author":"Cuddy","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.jchf.2026.103018_bib20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jchf.2026.103018_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"19","key":"10.1016\/j.jchf.2026.103018_bib22","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.jchf.2026.103018_bib23","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1161\/CIR.0000000000001354","article-title":"Speckle-tracking strain echocardiography for the assessment of left ventricular structure and function: a scientific statement from the American Heart Association","volume":"152","author":"Mihos","year":"2025","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ehjci\/jeae263","article-title":"Echocardiographic phenotype in severe aortic stenosis with and without transthyretin cardiac amyloidosis: the AMY-TAVI study","volume":"26","author":"Bastos-Fernandez","year":"2025","journal-title":"Eur Hear J Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2026.103018_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2023.04.048","article-title":"Predictive value of relative apical sparing of longitudinal strain on echocardiography for cardiac amyloidosis","volume":"200","author":"Bavishi","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.103018_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2023.06.022","article-title":"How often does apical sparing of longitudinal strain indicate the presence of cardiac amyloidosis?","volume":"202","author":"Wali","year":"2021","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.jchf.2026.103018_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/echo.15962","article-title":"Comparing echocardiographic strain imaging in cardiac amyloid and end-stage renal disease patients","volume":"41","author":"Ferris","year":"2024","journal-title":"Echocardiography"},{"issue":"7","key":"10.1016\/j.jchf.2026.103018_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.echo.2020.03.012","article-title":"Reduced diagnostic accuracy of apical-sparing strain abnormality for cardiac amyloidosis in patients with chronic kidney disease","volume":"33","author":"Singh","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"10.1016\/j.jchf.2026.103018_bib29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2022.1781","article-title":"A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"7","author":"Davies","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2026.103018_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-22876-9","article-title":"A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy","volume":"12","author":"Huda","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jchf.2026.103018_bib31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cardfail.2023.11.017","article-title":"EstimATTR: a simplified, machine-learning-based tool to predict the risk of wild-type transthyretin amyloid cardiomyopathy","volume":"30","author":"Castano","year":"2024","journal-title":"J Card Fail"},{"issue":"13","key":"10.1016\/j.jchf.2026.103018_bib32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.118.034338","article-title":"Fully automated echocardiogram interpretation in clinical practice: feasibility and diagnostic accuracy downloaded","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jchf.2026.103018_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005289","article-title":"Automated and interpretable patient ECG profiles for disease detection, tracking, and discovery","volume":"12","author":"Tison","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.jchf.2026.103018_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamacardio.2021.6059","article-title":"High-throughput precision phenotyping of left ventricular hypertrophy with cardiovascular deep learning","volume":"7","author":"Duffy","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2026.103018_bib35","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1038\/s41467-021-22877-8","article-title":"Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms","volume":"12","author":"Goto","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jchf.2026.103018_bib36","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.mayocp.2021.04.023","article-title":"Artificial intelligence\u2013enhanced electrocardiogram for the early detection of cardiac amyloidosis","volume":"96","author":"Grogan","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.jchf.2026.103018_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100612","article-title":"Postdevelopment performance and validation of the artificial intelligence-enhanced electrocardiogram for detection of cardiac amyloidosis","volume":"2","author":"Harmon","year":"2023","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cvdhj.2023.03.001","article-title":"Artificial intelligence\u2013enabled classification of hypertrophic heart diseases using electrocardiograms","volume":"4","author":"Haimovich","year":"2023","journal-title":"Cardiovasc Digit Heal J"},{"issue":"40","key":"10.1016\/j.jchf.2026.103018_bib39","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1093\/eurheartj\/ehaf387","article-title":"Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool","volume":"46","author":"Slivnick","year":"2025","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib40","article-title":"Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements","volume":"11","author":"Chang","year":"2024","journal-title":"Open Hear"},{"key":"10.1016\/j.jchf.2026.103018_bib41","author":"Browning"},{"issue":"8 suppl","key":"10.1016\/j.jchf.2026.103018_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0735-1097(23)00782-9","article-title":"Anti-racist AI: a machine learning model using electrocardiograms and echocardiograms can detect transthyretin cardiac amyloidosis and decrease racial bias in diagnostic testing","volume":"81","author":"Jain","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamacardio.2025.4591","article-title":"Detecting transthyretin cardiac amyloidosis with artificial intelligence a nonrandomized clinical trial","volume":"11","author":"Jain","year":"2026","journal-title":"JAMA Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.jchf.2026.103018_bib44","article-title":"External validation of EchoNet-LVH, a deep learning model for cardiac amyloidosis, for association with cardiomyopathy (abstract 4146940)","volume":"150","author":"Castellote","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103018_bib45","series-title":"CA-AI echo: diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study","author":"Ioannou","year":"2024"},{"key":"10.1016\/j.jchf.2026.103018_bib47","series-title":"Independent external validation of deep learning-based echocardiographic detection of cardiac amyloidosis using a global multiethnic population","author":"Randazzo","year":"2025"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib48","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jcmg.2023.05.002","article-title":"Development and validation of a prediction model and score for transthyretin cardiac amyloidosis diagnosis: T-Amylo","volume":"16","author":"Arana-Achaga","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.jchf.2026.103018_bib49","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.cardfail.2024.11.016","article-title":"Performance of clinical scoring systems in the diagnosis of transthyretin amyloid cardiomyopathy in a diverse patient cohort","volume":"31","author":"Greenberg","year":"2025","journal-title":"J Card Fail"},{"issue":"8","key":"10.1016\/j.jchf.2026.103018_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101901","article-title":"Evaluating the performance and potential bias of predictive models for detection of transthyretin cardiac amyloidosis","volume":"4","author":"Hourmozdi","year":"2025","journal-title":"JACC Adv"},{"issue":"10","key":"10.1016\/j.jchf.2026.103018_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jacadv.2024.101233","article-title":"Is it time for population-based screening for transthyretin cardiac amyloidosis?","volume":"3","author":"Goyal","year":"2024","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCULATIONAHA.125.075097","article-title":"The promise and peril of learning algorithms and predictive models in clinical decision support: be careful what you train for","volume":"152","author":"Martyn","year":"2025","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jchf.2026.103018_bib53","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.3390\/jcm13206150","article-title":"Race, sex, and ejection fraction-based differences in transthyretin amyloid cardiomyopathy (ATTR-CM) risk prediction","volume":"13","author":"Chedid","year":"2024","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.jchf.2026.103018_bib54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jchf.2022.06.006","article-title":"Racial and genetic differences in presentation of transthyretin amyloid cardiomyopathy with impaired left ventricular function","volume":"10","author":"Martyn","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"22","key":"10.1016\/j.jchf.2026.103018_bib55","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"10.1016\/j.jchf.2026.103018_bib56","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1093\/eurheartj\/ehaf450","article-title":"Artificial intelligence-enabled electrocardiography and echocardiography to track preclinical progression of transthyretin amyloid cardiomyopathy","volume":"46","author":"Oikonomou","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103018_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40985-018-0093-8","article-title":"Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis","volume":"39","author":"Iragorri","year":"2018","journal-title":"Public Health Rev"},{"key":"10.1016\/j.jchf.2026.103018_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1204","article-title":"Economic evaluation of health interventions","volume":"337","author":"Drummond","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2026.103018_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131598","article-title":"Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States","volume":"398","author":"Lau","year":"2024","journal-title":"Int J Cardiol"},{"issue":"18","key":"10.1016\/j.jchf.2026.103018_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026308","article-title":"Modeling the cost and health impacts of diagnostic strategies in patients with suspected transthyretin cardiac amyloidosis","volume":"11","author":"Ge","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jchf.2026.103018_bib61","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028534","article-title":"Design and rationale the SCAN (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) study","volume":"12","author":"Ruberg","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.jchf.2026.103018_bib62","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamacardio.2025.2948","article-title":"Transthyretin cardiac amyloidosis in older Black and Hispanic individuals with heart failure","volume":"10","author":"Ruberg","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2026.103018_bib63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cardfail.2024.08.055","article-title":"Should we systematically screen for the amyloidogenic V142I variant?","volume":"31","author":"Regan","year":"2025","journal-title":"J Card Fail"},{"issue":"6","key":"10.1016\/j.jchf.2026.103018_bib64","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.recesp.2023.12.016","article-title":"Results of a population screening program for hereditary transthyretin amyloidosis","volume":"77","author":"De Frutos","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"17","key":"10.1016\/j.jchf.2026.103018_bib65","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jchf.2026.103018_bib66","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhsa.2019.06.016","article-title":"Carpal tunnel syndrome: a potential early, red-flag sign of amyloidosis","volume":"44","author":"Donnelly","year":"2019","journal-title":"J Hand Surg Am"},{"issue":"7","key":"10.1016\/j.jchf.2026.103018_bib67","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.mayocp.2023.11.016","article-title":"Carpal tunnel syndrome and transthyretin amyloidosis in the All of Us research program","volume":"99","author":"Shetty","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.jchf.2026.103018_bib68","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000006816","article-title":"Amyloidosis screening by biopsy during carpal tunnel release: a systematic review and meta-analysis","volume":"13","author":"Ferrin","year":"2025","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jchf.2026.103018_bib70","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030271","article-title":"Amyloid transthyretin cardiomyopathy in elderly patients with aortic stenosis undergoing transcatheter aortic valve implantation","volume":"12","author":"Dobner","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jchf.2026.103018_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.jchf.2026.103018_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102890","article-title":"Early diagnosis of ATTR-CM using carpal tunnel biopsy examination: EDUCATE: a United Kingdom prospective multicenter study","volume":"14","author":"Razvi","year":"2026","journal-title":"JACC Heart Fail"},{"issue":"14","key":"10.1016\/j.jchf.2026.103018_bib73","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3390\/jcm11144120","article-title":"RWT\/SaVR\u2014a simple and highly accurate measure screening for transthyretin cardiac amyloidosis","volume":"11","author":"Arnberg","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7812\/TPP\/22.135","article-title":"Transthyretin amyloid cardiomyopathy risk evaluation in a cohort of patients with heart failure","volume":"27","author":"Suh","year":"2023","journal-title":"Perm J"},{"issue":"7","key":"10.1016\/j.jchf.2026.103018_bib75","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/echo.15626","article-title":"Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result","volume":"40","author":"Nagai","year":"2023","journal-title":"Echocardiography"},{"issue":"4","key":"10.1016\/j.jchf.2026.103018_bib76","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/ehf2.14786","article-title":"Transthyretin amyloid cardiomyopathy among patients with heart failure and preserved ejection fraction: the AMY score","volume":"11","author":"Gioia","year":"2024","journal-title":"ESC Hear Fail"},{"key":"10.1016\/j.jchf.2026.103018_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132664","article-title":"A multicenter study of clinical predictors of positive pyrophosphate scintigraphy findings in the diagnosis of transthyretin amyloidosis","volume":"418","author":"Shingu","year":"2025","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.jchf.2026.103018_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007284","article-title":"Age and sex estimation using artificial intelligence from standard 12-lead ECGs","volume":"12","author":"Attia","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"10.1016\/j.jchf.2026.103018_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102067","article-title":"International validation of echocardiographic artificial intelligence amyloid detection algorithm","volume":"4","author":"Duffy","year":"2025","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.jchf.2026.103018_bib80","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2589-7500(24)00249-8","article-title":"Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study","volume":"7","author":"Oikonomou","year":"2025","journal-title":"Lancet Digit Health"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:37:13Z","timestamp":1788316633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177926001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213177926001174"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103018","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening Strategies for Identification of Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"103018"}}